Jacob Gottlieb to Share Office Space with Stuart Weisbrod

Healthcare investor Jacob Gottlieb has been helping people find opportunities in the healthcare space. Now, he is re-joining a fellow healthcare investor as the two share an office space. Today, the funds of Jacob Gottlieb and Stuart Weisbrod are now doing operating their respective businesses from the same address.

Stuart Weisbrod is best known for co-foudning Merlin in 1998. Merlin was a top tier healthcare fund with portfolio investments in pharmaceutical, medical device, biotechnology, and healthcare service sectors. Weisbrod kept an impressive team of healthcare investment experts on his team. One of those team members was none other than Jacob Gottlieb.

Gottlieb was one of the stars at Merlin. During the biotechnology boom of 2000, Gottlieb led his healthcare portfolio to triple digit returns in 1999 and 2000. Both Weisbrod and Gottlieb were able to enjoy years of success throughout the first half of the 2000s. In 2007, Weisbrod decided to close his doors and return funds back to investors.

After closing Merlin, Weisbrod decided that he wanted to get back into the game and opened up Iguana Healthcare Partners. Much like Merlin, Iguana focused on publicly traded healthcare companies in the pharmaceutical, healthcare service, biotechnology, diagnostic, medical device, and healthcare information technology space.

Much like his former boss, Jacob Gottlieb decided to open his own fund as well – Visium Asset Management. The fund started with $300 million. That initial capital grew quickly to over $2.5 billion. The fund was able to survive the 2008 crash and continue to grow to over $8 billion in assets under management and 200 employees in three offices. The fund would eventually close in 2016.

Today, Jacob Gottlieb and Stuart Weisbrod find themselves under the same roof once again. This time, the two are working independently of each other. However, it would not be surprising if these two veteran healthcare investors later combine forces to create another healthcare investing juggernaut.

This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *